Please login to the form below

Not currently logged in


This page shows the latest Emgality news and features for those working in and with pharma, biotech and healthcare.

Eli Lilly focuses on 2022 launches as revenues climb by 18%

Eli Lilly focuses on 2022 launches as revenues climb by 18%

Diabetes medicine Trulicity (dulaglutide), immunology blockbuster Taltz (ixekizumab), breast cancer therapy Verzenio (abemaciclib) and migraine prevention antibody Emgality (galcanezumab-gnlm) each saw revenues rise by more than 30% year on year.

Latest news

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....